Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
- PMID: 28446172
- PMCID: PMC5405469
- DOI: 10.1186/s12931-017-0559-0
Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
Abstract
Eosinophilic COPD appears to be a distinct patient subgroup with an increased corticosteroid response. Eosinophilic COPD has been labelled as part of the asthma COPD overlap syndrome (ACOS). We compared the clinical characteristics of eosinophilic COPD patients (without any clinical history of asthma) and COPD patients with a childhood history of asthma. COPD patients with asthma were characterised by more allergies and more exacerbations, but less eosinophilic inflammation. While terms such as "ACOS" are used to "lump" patients together, we report distinct differences between eosinophilic COPD and COPD patients with asthma, and propose that these groups should be split rather than lumped.
Keywords: ACOS; Asthma COPD overlap; COPD; Eosinophils.
Similar articles
-
Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.Respirology. 2021 Jan;26(1):52-61. doi: 10.1111/resp.13841. Epub 2020 May 19. Respirology. 2021. PMID: 32428971
-
Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?Allergy. 2017 Jan;72(1):137-145. doi: 10.1111/all.13004. Epub 2016 Sep 27. Allergy. 2017. PMID: 27501862
-
Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.COPD. 2018 Apr;15(2):177-184. doi: 10.1080/15412555.2018.1441275. Epub 2018 Mar 20. COPD. 2018. PMID: 29558236
-
Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.Curr Drug Targets. 2018;19(16):1882-1896. doi: 10.2174/1389450119666180212120012. Curr Drug Targets. 2018. PMID: 29437007 Free PMC article. Review.
-
The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.Curr Opin Pulm Med. 2015 Jan;21(1):74-9. doi: 10.1097/MCP.0000000000000118. Curr Opin Pulm Med. 2015. PMID: 25405671 Review.
Cited by
-
Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids.Front Pharmacol. 2019 Jul 25;10:765. doi: 10.3389/fphar.2019.00765. eCollection 2019. Front Pharmacol. 2019. PMID: 31404293 Free PMC article.
-
Clinical Predictors of High Blood Eosinophils in Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2021 Aug 28;16:2467-2474. doi: 10.2147/COPD.S324511. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34483658 Free PMC article.
-
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects.Tuberc Respir Dis (Seoul). 2020 Jul;83(3):185-194. doi: 10.4046/trd.2020.0026. Epub 2020 Apr 29. Tuberc Respir Dis (Seoul). 2020. PMID: 32578413 Free PMC article.
-
ILC2 Diversity, Location, and Function in Pulmonary Disease.Immunol Rev. 2025 Jul;332(1):e70036. doi: 10.1111/imr.70036. Immunol Rev. 2025. PMID: 40454563 Free PMC article. Review.
-
The Combined Value of Type2 Inflammatory Markers in Chronic Obstructive Pulmonary Disease.J Clin Med. 2022 May 16;11(10):2791. doi: 10.3390/jcm11102791. J Clin Med. 2022. PMID: 35628917 Free PMC article.
References
-
- Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Blood Eosinophils and Exacerbations in COPD: the Copenhagen General Population Study. Am J Respir Crit Care Med. 2015 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical